Strengthen Medical Cannabis Submission Guidelines for stricter control. - Tightened regulations adopted for distributing medical cannabis
In a significant move towards regulating medical cannabis, Nina Warken, the new Federal Minister of Health, has proposed a bill that aims to prevent the misuse of medical cannabis due to a significant increase in consumption. The bill, which is yet to be passed into law, has sparked debates and raised questions about the future of medical cannabis prescriptions and dispensing in Germany.
Since the Cannabis Act came into force in April 2024, imports of cannabis flowers for medical purposes have seen a dramatic increase, with imports rising by 170% from the first half to the second half of the year. The Federal Institute for Drugs and Medical Devices reported this increase, and the bill refers to these growing imports.
The bill, however, does not specify any penalties for pharmacies that fail to fulfill the consultation obligations, a key aspect of the proposed regulatory changes. The bill does state comprehensive information and consultation obligations for medical cannabis, with these obligations needing to be fulfilled during a consultation at the pharmacy.
The ABDA, the Federal Association of German Pharmacists' Associations, has welcomed the bill, with ABDA President Thomas Preis explaining that medicines are not ordinary consumer goods and do not belong on purely commercially oriented trading platforms. The ABDA supports the bill's requirement for comprehensive information and consultation obligations during a consultation at the pharmacy.
The shift away from online prescriptions for medical cannabis is another notable aspect of the bill. The bill does not mention any specific reasons for this change, but Warken aims to prevent easy online prescribing of cannabis due to the rise in consumption.
The bill does not respond to requests for comment from the Federal Ministry of Health regarding the bill. As of the time of this news article, the increase in prescriptions for medical cannabis at the expense of statutory health insurance has only increased by nine percent in the same period, with the Federal Ministry of Health attributing this low increase to an increasing number of private prescriptions from self-payers and procurement via online platforms.
In the future, medical cannabis can only be picked up at local pharmacies, according to the bill. The specifics of the new rules for medical cannabis dispensing introduced in the bill by Nina Warken (CDU) are yet to be fully understood, particularly regarding telemedicine, pharmacy pick-up, or consultation obligations. It is recommended to consult the official legislative text or government announcements directly related to her proposal for precise details.
It is worth noting that legislative efforts around medical cannabis often focus on allowing or regulating telemedicine consultations for prescribing medical cannabis to increase patient access while ensuring proper medical oversight, defining or expanding pharmacy pick-up options to facilitate patient convenience and control distribution channels, and establishing clear consultation obligations so that patients receive appropriate medical guidance on usage, doses, and possible side effects.
The new bill proposes a significant shift in the way medical cannabis is prescribed and dispensed in Germany. As the bill progresses through the legislative process, more details are expected to emerge, providing clarity on the specific regulatory changes and provisions in the bill.
- The proposed bill by Nina Warken, the Federal Minister of Health, specifically refers to the rising imports of cannabis flowers for medical purposes as observed by the Federal Institute for Drugs and Medical Devices.
- A key aspect of the bill is the requirement for comprehensive information and consultation obligations during a consultation at the pharmacy, as supported by the ABDA, the Federal Association of German Pharmacists' Associations.
